Serum insulin-like growth factors and their binding proteins in children with end-stage renal disease

Pediatric Nephrology

Volumn 10, Issue 3, 1996, Pages 269-274

  Tönshoff, Burkhard ^a   Blum, Werner F ^b   Mehls, Otto ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b LILLY DEUTSCHLAND GMBH   (Germany)

Author keywords

End stage renal disease; Growth retardation; Insulin like growth factor binding proteins; Insulin like growth factors

Indexed keywords

GROWTH HORMONE; IODINE 125; SOMATOMEDIN; SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 2; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ADULT; BINDING AFFINITY; BLOOD LEVEL; CHILD; CONFERENCE PAPER; CONTROLLED STUDY; CROSS LINKING; FEMALE; GROWTH DISORDER; GROWTH HORMONE BLOOD LEVEL; HUMAN; IMMUNOPRECIPITATION; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MOLECULAR WEIGHT; NEWBORN; PRIORITY JOURNAL; RADIOIMMUNOASSAY;

EID: 0030003041     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00866755     Document Type: Conference Paper

References (37)

1. Tönshoff B, Fine RN (1995) Growth and growth hormone treatment in children with chronic renal insufficiency. In: Nissenson AR, Fine RN, Gentile DE (eds) Clinical dialysis. Appleton and Lange, East Norwalk, Connecticut, pp 549-573
2. Tönshoff B, Mehls O (1995) Growth retardation in children with chronic renal insufficiency: current aspects of pathophysiology and treatment. J Nephrol 8: 133-142
3. Phillips LS, Pennisi AJ, Belosky DC, Uittenbogaart C, Ettenger RB, Malekzadeh MH, Fine RN (1978) Somatomedin activity and inorganic sulfate in children undergoing hemodialysis. J Clin Endocrinol Metab 46: 165-168
4. Phillips LS, Fusco AC, Unterman TG, Del Greco F (1984) Somatomedin inhibitor in uremia. J Clin Endocrinol Metab 59: 764-772
5. Blum WF, Ranke MB, Kietzmann K, Tönshoff B, Mehls O (1991) Growth hormone resistance and inhibition of somatomedin activity by excess of insulin-like growth factor binding protein in uremia. Pediatr Nephrol 5: 539-544
6. Roth RA, Steele-Perkins G, Hari J, Stover C, Pierce S, Turner J, Edman JC, Rutter WJ (1988) Insulin and insulin-like growth factor receptors and responses. Cold Spring Harb Symp Quant Biol 13: 537-543
7. Shimasaki S, Shimonaka M, Zhang H, Ling N (1991) Isolation and molecular characterization of three novel insulin-like growth factor binding protein (IGFBP-4, 5 and 6). In: Spencer EM (ed) Modern concepts of insulin-like growth factors. Elsevier, New York, pp 343-358
8. Lee PDK, Conover CA, Powell DR (1993) Regulation and function of insulin-like growth factor-binding protein-1. Proc Soc Exp Biol Med 204: 4-29
9. Ritvos O, Rama T, Jalkanen J, Suikkari A-M, Voutilainen R, Bohn H, Rutanen E-M (1988) Insulin-like growth factor (IGF) binding protein from human decidua inhibits the binding and biological action of IGF-I in cultured choriocarcinoma cells. Endocrinology 122: 2150-2157
10. Burch WM, Correa J, Shively JE, Powell DR (1990) The 25-kilodalton insulin-like growth factor (IGF)-binding protein inhibits both basal and IGF-I-mediated growth of chick embryo pelvic cartilages in vitro. J Clin Endocrinol Metab 70: 173-180
11. Baxter RC, Martin JL, Beniac VA (1989) High molecular weight insulin-like growth factor binding protein complex. J Biol Chem 264: 11843-11848
12. Blum WF, Albertsson-Wikland K, Rosberg S, Ranke MB (1993) Serum levels of insulin-like growth factor I (IGF-I) and IGF binding protein 3 reflect spontaneous growth hormone secretion. J Clin Endocrinol Metab 76: 1610-1616
13. De Mellow JS, Baxter RC (1988) Growth hormone-dependent insulin-like growth factor (IGF) binding protein both inhibits and potentiates IGF-I-stimulated DNA synthesis in human skin fibroblasts. Biochem Biophys Res Commun 156: 199-204
14. Conover CA, Ronk M, Lombana F, Powell DR (1990) Structural and biological characterization of bovine insulin-like growth factor binding protein-3. Endocrinology 127: 2795-2803
15. Blum WF, Jenne EW, Reppin F, Kietzmann K, Ranke MB, Bierich JR (1989) Insulin-like growth factor I (IGF-I)-binding protein complex is a better mitogen than free IGF-I. Endocrinology 125: 766-772
16. Bicsak TA, Shimonaka M, Malkowski M, Ling M (1990) Insulin-like growth factor-binding protein (IGF-BP) inhibition of granulosa cell function: effect on cyclic adenosine 3′,5′-monophosphate, deoxyribonucleic acid synthesis, and comparison with the effect of an IGF-I antibody. Endocrinology 126: 2184-2189
17. Blum WF, Ranke MB, Kietzmann K, Tönshoff B, Mehls O (1989) Excess of IGF-binding proteins in chronic renal failure: evidence for relative GH resistance and inhibition of somatomedian activity. In: Drop SLS, Hintz RL (eds) Insulin-like growth factor binding proteins. Excerpta Medica, Amsterdam, pp 93-101
18. Blum WF (1991) Insulin-like growth factors (IGFs) and IGF binding proteins in chronic renal failure: evidence for reduced secretion of IGFs. Acta Paediatr Scand [Suppl] 379: 24-31
19. Tönshoff B, Blum WF, Wingen A, Mehls O (1995) Serum insulin-like growth factors (IGFs) and IGF binding proteins 1, 2 and 3 in children with chronic renal failure: relationship to height and glomerular filtration rate. J Clin Endocrinol Metab 80: 2684-2691
20. Powell D, Rosenfeld R, Sperry J, Baker B, Hintz R (1987) Serum concentrations of insulin-like growth factor (IGF)-I, IGF-2 and unsaturated somatomedin carrier proteins in children with chronic renal failure. Am J Kidney Dis 10: 287-292
21. Lee PDK, Hintz RL, Sperry JB, Baxter RC, Powell DR (1989) IGF binding proteins in growth-retarded children with chronic renal failure. Pediatr Res 26: 308-315
22. Liu F, Powell DR, Hintz RL (1990) Characterization of insulin-like growth factor binding proteins in human serum from patients with chronic renal failure. J Clin Endocrinol Metab 70: 620-628
23. Powell DR, Liu F, Baker B, Lee PDK, Belsha CW, Brewer ED, Hintz RL (1993) Characterization of insulin-like growth factor binding protein-3 in chronic renal failure serum. Pediatr Res 33: 136-143
24. Blum WF, Ranke MB, Bierich JR (1988) A specific radioimmunoassay for insulin-like growth factor II: the interference of IGF binding proteins can be blocked by excess IGF-I. Acta Endocrinol (Copenh) 118: 374-380
25. Breier BH, Milsom SR, Blum WF, Schwander J, Gallaher BW, Gluckman PD (1993) Insulin-like growth factors and their binding proteins in plasma and milk after growth hormone-stimulated galactopoiesis in normally lactating women. Acta Endocrinol (Copenh) 129: 427-435
26. Blum WF, Horn N, Kratzsch J, Jorgensen JOL, Juul A. Teale D, Mohnike K, Ranke MB (1993) Clinical studies of IGFBP-2 by radioimmunoassay. Growth Regulation 3: 100-104
27. Blum WF, Ranke MB, Kietzmann K, Gauggel E, Zeisel HJ, Bierich JR (1990) A specific radioimmunoassay for the growth hormone (GH)-dependent somatomedin-bmding protein: its use for diagnosis of GH deficiency. J Clin Endocrinol Metab 70: 1292-1298
28. Wilkins JR, D'Ercole AJ (1985) Affinity-labeled plasma somatomedin-C/insulin-like growth factor I binding proteins. Evidence of growth hormone dependence and subunit structure. J Clin Invest 75: 1350-1358
29. Blum WF (1992) Insulin-like growth factors and their binding proteins. In: Ranke MB (ed) Functional endocrinologic diagnostics in children and adolescence. J&J Verlag, Mannheim, pp 102-117
30. Zar JH (1984) Biostatistical analysis, Prentice-Hall, Englewood Cliffs, New Jersey
31. Tonshoff B, Veldhuis JD, Heinrich U, Mehls O (1995) Deconvolution analysis of spontaneous nocturnal growth hormone secretion in prepubertal children with chronic renal failure. Pediatr Res 37: 86-93
32. Tonshoff B, Powell DR, Zhao DL, Domene HM, Blum WF, Moore LC, Kaskel FJ (1995) Decreased hepatic insulin-like growth factor (IGF)-I and increased IGF binding protein (IGFBP)-I and -2 gene expression in experimental uremia (abstract). J Am Soc Nephrol 6: 1032
33. Tönshoff B, Dietz M, Haffner D, Tönshoff C, Stöver B, Mehls O (1991) Effects of two years growth hormone treatment in short children with renal disease. Acta Paediatr Scand [Suppl] 379: 33-41
34. Baxter RC (1993) IGF binding protein-3 and the acid-labile subunit: formation of the ternary complex in vitro and in vivo. In: LeRoith D, Raizada MK (eds) Current directions in insulin-like growth factor research. Plenum, New York, pp 237-244
35. Bentham J, Rodriguez-Arnao J, Ross RJM (1993) Acquired growth resistance in patients with hypercatabolism. Horm Res 40: 87-91
36. Holly JM, Claffey DC, Cwyfan-Hughes SC, Frost VJ, Yateman ME (1993) Proteases acting on IGFBPs: their occurrence and physiological significance. Growth Regulation 3: 88-91
37. Lee D, Park S, Yorgin PD, Cohen P, Oh Y, Rosenfeld RG (1994) Alterations in insulin-like growth factor-binding proteins (IGFBPs) and IGFBP-3 protease activity in serum and urine from acute and chronic renal failure. J Clin Endocrinol Metab 79: 1376-1382